- Home
- RCUS vs TRS Comparison
RCUS vs TRS Comparison
Compare RCUS & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TRS
- Stock Information
- Founded
- RCUS 2015
- TRS 1986
- Country
- RCUS United States
- TRS United States
- Employees
- RCUS N/A
- TRS N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TRS Industrial Specialties
- Sector
- RCUS Health Care
- TRS Industrials
- Exchange
- RCUS Nasdaq
- TRS Nasdaq
- Market Cap
- RCUS 906.4M
- TRS 1.0B
- IPO Year
- RCUS 2018
- TRS 2007
- Fundamental
- Price
- RCUS $8.92
- TRS $26.37
- Analyst Decision
- RCUS Buy
- TRS Strong Buy
- Analyst Count
- RCUS 11
- TRS 1
- Target Price
- RCUS $25.33
- TRS $40.00
- AVG Volume (30 Days)
- RCUS 1.2M
- TRS 374.9K
- Earning Date
- RCUS 05-06-2025
- TRS 04-29-2025
- Dividend Yield
- RCUS N/A
- TRS 0.61%
- EPS Growth
- RCUS N/A
- TRS N/A
- EPS
- RCUS N/A
- TRS 0.77
- Revenue
- RCUS $141,000,000.00
- TRS $939,580,000.00
- Revenue This Year
- RCUS N/A
- TRS $6.37
- Revenue Next Year
- RCUS $29.83
- TRS $3.56
- P/E Ratio
- RCUS N/A
- TRS $34.24
- Revenue Growth
- RCUS N/A
- TRS 3.80
- 52 Week Low
- RCUS $6.50
- TRS $19.33
- 52 Week High
- RCUS $18.98
- TRS $28.51
- Technical
- Relative Strength Index (RSI)
- RCUS 53.03
- TRS 65.54
- Support Level
- RCUS $8.42
- TRS $25.35
- Resistance Level
- RCUS $9.61
- TRS $26.73
- Average True Range (ATR)
- RCUS 0.49
- TRS 0.66
- MACD
- RCUS 0.06
- TRS 0.09
- Stochastic Oscillator
- RCUS 48.89
- TRS 88.31
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.